Aimmune is a leader in developing desensitization treatments designed to reduce the frequency and severity of allergic reactions.

Recent News

Aimmune to Participate in Three Upcoming Investor Conferences
New Data Presented at ACAAI 2019 Show Importance of Clinical History in Identifying AR101-Eligibile Patients for PALISADE Study without a Food Challenge
Quality of Life Outcomes from Two New Surveys Highlight Emotional Impact of Peanut Allergy and Need for New Treatments
READ ALL NEWS

INVESTORS AND MEDIA

See the Future

Peanut allergy is just the start. We are targeting the world’s most prevalent food allergies and you’re invited to experience it for yourself.
SEE WHAT'S HAPPENING AT AIMMUNE

CAREERS

Join Our Team

We’re building a team that aims to transform how food allergies are treated. Learn more about our company and explore current openings.
CAREERS AT AIMMUNE